SoftOx Solutions AS — Regulatory Filings 2021

Dec 1, 2021

The EU Commission's interpretation of the Biocidal Regulations can allow SoftOx to enter the market with all its disinfectant products in the EU and EEA area

The EU Commission's interpretation of the Biocidal Regulations can allow SoftOx to enter the market with all its disinfectant products in the EU and EEA area

SoftOx Solutions AS (SoftOx) has previously been refused on a request for a transitional arrangement from the Norwegian Environment Agency for its hand disinfection products. In this context, the company has requested an assessment and a clarifying statement from the European Commission.

Will be able to deliver on the National Hospital Tender (HINAS) and European markets

The company's interpretation of the Biocidal Regulations is in line with the Commission's statement regarding the possible transitional arrangements for the company's hand and surface disinfectants.

“This is very good news for SoftOx. In our opinion the European Commission's assessment will enable us to make our products available on the market and we will be able to fulfil our obligations in accordance with the HINAS agreement. The European Commission's analysis and assessment means that SoftOx can, if the company wants to, go to all European markets with its disinfectant products for hand and surface”, says CEO Geir Almås.

“We are ready to meet increased demand”

The company have a pending application in process in the Norwegian Environment Agency for approval of the company's hand and surface disinfection products. The transitional arrangement described by the EU Commission gives the company the opportunity to have the hand and surface products on the market until final approval of the pending application is available.

“This is a scenario we have prepared for by buying 50 percent of Ose Water. We are ready to meet potential increased demand from major European markets”, according to Almås.

For further information, please contact:

CEO Geir Almås of SoftOx Solutions AS, or

CFO Kristine M. Rød of SoftOx Solutions AS

Mail: ir@soft-ox.com

Mobile: (+47) 948 59 599

The information included in this announcement is defined as inside information

pursuant to MAR article 7, and is publicly disclosed in accordance with MAR

article 17. The announcement is made by the contact person.

About SoftOx Solutions AS

SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Norwegian

BioTech company based in Oslo with the aim of helping to combat major threats to

human health, namely the emergence of antimicrobial resistance (AMR), biofilm

infections in chronic wounds and the spread of viruses. For more information on

SoftOx, visit www.soft-ox.com.